 <h1>Trandolapril / verapamil Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of trandolapril/verapamil include:</b> sinus bradycardia. <b>Other side effects include:</b> bradycardia, first degree atrioventricular block, and second degree atrioventricular block.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to trandolapril / verapamil: oral tablet extended release</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet, Extended Release)</p><p>Discontinue treatment with trandolapril/verapamil hydrochloride as soon as possible when pregnancy is detected, since fetal toxicity, including injury and death to the developing fetus, can be caused by drugs that act directly on the renin-angiotensin system.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, trandolapril / verapamil may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking trandolapril / verapamil:</p><p>
<i>Rare</i>
</p><ul>
<li>Chest pain</li>
<li>chills</li>
<li>cough (with mucus)</li>
<li>dark urine</li>
<li>fever</li>
<li>general feeling of discomfort or illness</li>
<li>lightheadedness or fainting</li>
<li>pain in the right side of the abdomen or stomach</li>
<li>slow heartbeat</li>
<li>sore throat</li>
<li>swelling of the face, mouth, hands, or feet</li>
<li>trouble in swallowing or breathing (sudden) accompanied by hoarseness</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of trandolapril / verapamil may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common or rare</i>
</p><ul>
<li>Constipation</li>
<li>cough (dry, continuous)</li>
<li>diarrhea</li>
<li>dizziness</li>
<li>itching</li>
<li>joint pain or pain in the arms or legs</li>
<li>nausea</li>
<li>unusual tiredness</li>
</ul><p>
<!-- end oral tablet extended release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to trandolapril / verapamil: oral tablet extended release</i></p><h3>General</h3><p>The most common adverse reactions were headache, upper respiratory tract infection, cough, atrioventricular block first degree, constipation, and dizziness.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Upper respiratory tract infection, cough, dyspnea, bronchitis, upper respiratory tract congestion</p>
<p><b>Frequency not reported</b>: Epistaxis</p>
<p></p>
<p>Verapamil:</p>
<p><b>Frequency not reported</b>: Pulmonary edema<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia/weakness, chest pain, edema, fatigue</p>
<p><b>Frequency not reported</b>: Malaise</p>
<p></p>
<p>Verapamil:</p>
<p><b>Frequency not reported</b>: Gynecomastia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, nausea, diarrhea</p>
<p><b>Frequency not reported</b>: Dyspepsia, dry mouth</p>
<p></p>
<p>Trandolapril:</p>
<p><b>Frequency not reported</b>: Pancreatitis</p>
<p></p>
<p>Verapamil:</p>
<p><b>Frequency not reported</b>: Gingival hyperplasia, reversible nonobstructive paralytic ileus<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Pain back, pain extremity, pain joint</p>
<p><b>Frequency not reported</b>: Arthralgias/myalgias<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Atrioventricular (AV) block first degree, bradycardia</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypotension</p>
<p><b>Frequency not reported</b>: Angina, AV block second degree, bundle branch block, flushing, myocardial infarction, palpitation, premature ventricular contraction, nonspecific ST-T changes, tachycardia</p>
<p></p>
<p>Verapamil:</p>
<p><b>Frequency not reported</b>: Congestive heart failure, AV block third degree, AV dissociation, claudication, vasculitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p>There has been one postmarketing report of paralysis (tetraparesis) with verapamil, which may have been caused by concomitant use of colchicine.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Headache, dizziness</p>
<p><b>Uncommon</b> (0.1% to 1%): Near syncope</p>
<p><b>Frequency not reported</b>: Drowsiness, hypesthesia, loss of balance, paresthesia, vertigo, tinnitus</p>
<p></p>
<p>Verapamil:</p>
<p><b>Frequency not reported</b>: Syncope, cerebrovascular accident, shakiness, somnolence</p>
<p><b>Postmarketing reports</b>: Tetraparesis<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Creatinine increased</p>
<p><b>Uncommon</b> (0.1% to 1%): BUN increased<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hyperlipidemia</p>
<p><b>Frequency not reported</b>: Gout, uric acid increased, hyperkalemia, hyponatremia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Liver enzymes increased</p>
<p><b>Frequency not reported</b>: Serum bilirubin increased<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Angioedema</p>
<p><b>Frequency not reported</b>: Pruritus, rash</p>
<p></p>
<p>Verapamil:</p>
<p><b>Frequency not reported</b>: Purpura, ecchymosis, exanthema, hair loss, hyperkeratosis, maculae, Stevens-Johnson syndrome, erythema multiform<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Impotence, endometriosis, hematuria, nocturia, polyuria, proteinuria</p>
<p></p>
<p>Verapamil:</p>
<p><b>Frequency not reported</b>: Urination increased, menstruation spotty<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Leukocytes decreased, neutrophils decreased, white blood cells low, neutrophils low, lymphocytes low, platelets low<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Insomnia, anxiety, mentation abnormal</p>
<p></p>
<p>Trandolapril:</p>
<p><b>Frequency not reported</b>: Libido decreased</p>
<p></p>
<p>Verapamil:</p>
<p><b>Frequency not reported</b>: Confusion, psychotic symptoms<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Vision blurred<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Verapamil:</p>
<p><b>Frequency not reported</b>: Galactorrhea/hyperprolactinemia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Tarka (trandolapril-verapamil)." Knoll Pharmaceutical Company, Whippany, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about trandolapril / verapamil</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>4 Reviews</li>
<li>Drug class: ACE inhibitors with calcium channel blocking agents</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Trandolapril and verapamil &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Tarka</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to trandolapril / verapamil: oral tablet extended release</i></p><h3>General</h3><p>The most common adverse reactions were headache, upper respiratory tract infection, cough, atrioventricular block first degree, constipation, and dizziness.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Upper respiratory tract infection, cough, dyspnea, bronchitis, upper respiratory tract congestion</p><p><b>Frequency not reported</b>: Epistaxis</p><p></p><p>Verapamil:</p><p><b>Frequency not reported</b>: Pulmonary edema<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia/weakness, chest pain, edema, fatigue</p><p><b>Frequency not reported</b>: Malaise</p><p></p><p>Verapamil:</p><p><b>Frequency not reported</b>: Gynecomastia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, nausea, diarrhea</p><p><b>Frequency not reported</b>: Dyspepsia, dry mouth</p><p></p><p>Trandolapril:</p><p><b>Frequency not reported</b>: Pancreatitis</p><p></p><p>Verapamil:</p><p><b>Frequency not reported</b>: Gingival hyperplasia, reversible nonobstructive paralytic ileus<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Pain back, pain extremity, pain joint</p><p><b>Frequency not reported</b>: Arthralgias/myalgias<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Atrioventricular (AV) block first degree, bradycardia</p><p><b>Uncommon</b> (0.1% to 1%): Hypotension</p><p><b>Frequency not reported</b>: Angina, AV block second degree, bundle branch block, flushing, myocardial infarction, palpitation, premature ventricular contraction, nonspecific ST-T changes, tachycardia</p><p></p><p>Verapamil:</p><p><b>Frequency not reported</b>: Congestive heart failure, AV block third degree, AV dissociation, claudication, vasculitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p>There has been one postmarketing report of paralysis (tetraparesis) with verapamil, which may have been caused by concomitant use of colchicine.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Headache, dizziness</p><p><b>Uncommon</b> (0.1% to 1%): Near syncope</p><p><b>Frequency not reported</b>: Drowsiness, hypesthesia, loss of balance, paresthesia, vertigo, tinnitus</p><p></p><p>Verapamil:</p><p><b>Frequency not reported</b>: Syncope, cerebrovascular accident, shakiness, somnolence</p><p><b>Postmarketing reports</b>: Tetraparesis<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Creatinine increased</p><p><b>Uncommon</b> (0.1% to 1%): BUN increased<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hyperlipidemia</p><p><b>Frequency not reported</b>: Gout, uric acid increased, hyperkalemia, hyponatremia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Liver enzymes increased</p><p><b>Frequency not reported</b>: Serum bilirubin increased<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Angioedema</p><p><b>Frequency not reported</b>: Pruritus, rash</p><p></p><p>Verapamil:</p><p><b>Frequency not reported</b>: Purpura, ecchymosis, exanthema, hair loss, hyperkeratosis, maculae, Stevens-Johnson syndrome, erythema multiform<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Impotence, endometriosis, hematuria, nocturia, polyuria, proteinuria</p><p></p><p>Verapamil:</p><p><b>Frequency not reported</b>: Urination increased, menstruation spotty<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Leukocytes decreased, neutrophils decreased, white blood cells low, neutrophils low, lymphocytes low, platelets low<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Insomnia, anxiety, mentation abnormal</p><p></p><p>Trandolapril:</p><p><b>Frequency not reported</b>: Libido decreased</p><p></p><p>Verapamil:</p><p><b>Frequency not reported</b>: Confusion, psychotic symptoms<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Vision blurred<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Verapamil:</p><p><b>Frequency not reported</b>: Galactorrhea/hyperprolactinemia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Tarka (trandolapril-verapamil)." Knoll Pharmaceutical Company, Whippany, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about trandolapril / verapamil</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>4 Reviews</li>
<li>Drug class: ACE inhibitors with calcium channel blocking agents</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Trandolapril and verapamil &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>